Returning individual research results: development of a cancer genetics education and risk communication protocol
- PMID: 20831418
- PMCID: PMC3159194
- DOI: 10.1525/jer.2010.5.3.17
Returning individual research results: development of a cancer genetics education and risk communication protocol
Abstract
The obligations of researchers to disclose clinically and/or personally significant individual research results are highly debated, but few empirical studies have addressed this topic. We describe the development of a protocol for returning research results to participants at one site of a multicenter study of the genetic epidemiology of melanoma. Protocol development involved numerous challenges: (1) deciding whether genotype results merited disclosure; (2) achieving an appropriate format for communicating results; (3) developing education materials; (4) deciding whether to retest samples for additional laboratory validation; (5) identifying and notifying selected participants; and (6) assessing the impact of disclosure. Our experience suggests potential obstacles depending on researcher resources and the design of the parent study, but offers a process by which researchers can responsibly return individual study results and evaluate the impact of disclosure.
Figures
References
-
- Banks TM. Misusing informed consent: A critique of limitations on research subjects’ access to genetic research results. Saskatchewan Law Review. 2000;63(2):539–580. - PubMed
-
- Baumanis L, Evans JP, Callanan N, Susswein LR. Telephoned BRCA1/2 genetic test results: Prevalence, practice, and patient satisfaction. Journal of Genetic Counseling. 2009;18(5):447–463. - PubMed
-
- Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, et al. A design for cancer case-control studies using only incident cases: Experience with the GEM study of melanoma. International Journal of Epidemiology. 2006;35(3):756–764. - PubMed
-
- Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. Journal of the National Cancer Institute. 2005;97(20):1507–1515. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical